课题基金 / 基金详情

Radiometals produced by liquid targets for molecular imaging of cancer

Radiometals produced by liquid targets for molecular imaging of cancer
液体靶材产生的放射性金属用于癌症分子成像
批准号:
248164
负责人:
Benard Francois
金额:
$30.6万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-10-01 至 2014-10-01

项目摘要

项目成果

Benard Francois的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
New breast cancer drugs are increasingly targeted to specific proteins involved in cancer progression, such as the epidermal growth factor receptor (HER2). These new drugs typically benefit only a small proportion of patients, at very high cost to the hea
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of second-generation radiopharmaceuticals targeting the C-X-C chemokine receptor 4 for imaging and therapy of hematological cancers
  • 批准号:
    463499
  • 项目类别:
    Operating Grants
  • 资助金额:
    $62.7万
  • 财政年份:
    2022
  • 负责人:
    Benard Francois
  • 依托单位:
Advancing the clinical development of [18F]AMBF3-TATE, a novel imaging probe for neuroendocrine tumours
  • 批准号:
    325063
  • 项目类别:
    Operating Grants
  • 资助金额:
    $11.66万
  • 财政年份:
    2015
  • 负责人:
    Benard Francois
  • 依托单位:
Targeted radiopharmaceuticals to improve cancer diagnosis and treatment
  • 批准号:
    334222
  • 项目类别:
    Operating Grants
  • 资助金额:
    $104.34万
  • 财政年份:
    2015
  • 负责人:
    Benard Francois
  • 依托单位:
Integrating Quantitative Imaging Methods and Genomic Biomarkers to Assess the Therapeutic Response of Cancers
  • 批准号:
    314278
  • 项目类别:
    Operating Grants
  • 资助金额:
    $112.84万
  • 财政年份:
    2014
  • 负责人:
    Benard Francois
  • 依托单位:
海外基金